The Food and Drug Administration (FDA) on Thursday announced a ban on 36 drugs for the treatment of stomach ulcers, as they have been found to pose a cancer risk.
The ban, which takes effect today, applies to drugs with the active ingredient ranitidine, which contains traces of the contaminant and probable carcinogen N-nitrosodimethylamine (NDMA), the agency said, citing international studies.
The studies also found that the NDMA levels in drugs increase over time and with exposure to heat, sometimes in excess of the maximum acceptable daily intake of 96 nanograms, the FDA said.
Prior to the ban, there were 36 drugs containing ranitidine marketed in Taiwan — 29 prescription drugs and seven over-the-counter medications, the FDA said in a press release.
The ban follows similar decisions by regulators in the US and Europe, where ranitidine products were withdrawn and suspended in April.
Retailers found selling the drugs would be fined between NT$60,000 and NT$1.5 million (US$2,034 and US$50,844) under the Consumer Protection Act (消費者保護法), while those who fail to comply with the recall guidelines risk being fined between NT$200,000 and NT$5 million, the FDA said.
More than 80 million doses of stomach ulcer drugs containing ranitidine are sold in the country each year, National Health Insurance Administration statistics showed.
Taiwanese drug companies on Thursday said that NDMA contamination is usually found in the raw materials used to make the drugs, but does not occur in the production process.
Ranitidine belongs to a family of drugs known as H2 blockers, which include famotidine and cimetidine, two viable substitutes, the companies added.
Two of the holders of drug permit licenses for ranitidine — China Chemical and Pharmaceutical Co and Standard Chemical and Pharmaceutical Co — said they had phased out production of ranitidine last year, after the release of research on its risks.
Yung Shin Pharmaceutical Industrial Co said it has a substitute for ranitidine and is unlikely to be significantly affected by the prohibition.
In 2018, the high blood pressure drug valsartan was recalled globally due to NDMA contamination.
The US’ FDA raised concerns about similar impurities in ranitidine products in September last year, prompting regulators in several countries to place the drug under review.
The manufacture of the remaining 28 M1A2T Abrams tanks Taiwan purchased from the US has recently been completed, and they are expected to be delivered within the next one to two months, a source said yesterday. The Ministry of National Defense is arranging cargo ships to transport the tanks to Taiwan as soon as possible, said the source, who is familiar with the matter. The estimated arrival time ranges from late this month to early next month, the source said. The 28 Abrams tanks make up the third and final batch of a total of 108 tanks, valued at about NT$40.5 billion
Travel agencies in Taiwan are working to secure alternative flights for travelers bound for New Zealand for the Lunar New Year holiday, as Air New Zealand workers are set to strike next week. The airline said that it has confirmed that the planned industrial action by its international wide-body cabin crew would go ahead on Thursday and Friday next week. While the Auckland-based carrier pledged to take reasonable measures to mitigate the impact of the workers’ strike, an Air New Zealand flight arriving at Taipei from Auckland on Thursday and another flight departing from Taipei for Auckland on Saturday would have to
A group from the Taiwanese Designers in Australia association yesterday represented Taiwan at the Midsumma Pride March in Melbourne. The march, held in the St. Kilda suburb, is the city’s largest LGBTQIA+ parade and the flagship event of the annual Midsumma Festival. It attracted more than 45,000 spectators who supported the 400 groups and 10,000 marchers that participated this year, the association said. Taiwanese Designers said they organized a team to march for Taiwan this year, joining politicians, government agencies, professionals and community organizations in showing support for LGBTQIA+ people and diverse communities. As the first country in Asia to legalize same-sex
MOTIVES QUESTIONED The PLA considers Xi’s policies toward Taiwan to be driven by personal considerations rather than military assessment, the Epoch Times reports Chinese President Xi Jinping’s (習近平) latest purge of the Chinese People’s Liberation Army (PLA) leadership might have been prompted by the military’s opposition to plans of invading Taiwan, the Epoch Times said. The Chinese military opposes waging war against Taiwan by a large consensus, putting it at odds with Xi’s vision, the Falun Gong-affiliated daily said in a report on Thursday, citing anonymous sources with insight into the PLA’s inner workings. The opposition is not the opinion of a few generals, but a widely shared view among the PLA cadre, the Epoch Times cited them as saying. “Chinese forces know full well that
RSS